ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Yuan Shao,Bo Wu,Zhen Yang,Zihao Liu,Yuan Ma, Hua Huang,Yang Liu, Zeyuan Wang, Weijing Hu,Yong Wang,Yuanjie Niu

Translational andrology and urology（2023）

引用 0|浏览3

暂无评分

摘要

As a potential prognostic biomarker for patients with ccRCC, downregulation of ALDOB was closely associated with the clinicopathological features, poor prognosis, immune infiltration, and m6A modification in ccRCC patients.

查看译文

关键词

Aldolase B (ALDOB), clear cell renal cell carcinoma (ccRCC), biomarker, prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要